Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC

被引：0
|
作者：
Shunichi Sugawara
Kazuhiko Nakagawa
Nobuyuki Yamamoto
Hiroshi Nokihara
Yuichiro Ohe
Makoto Nishio
Toshiaki Takahashi
Koichi Goto
Makoto Maemondo
Yukito Ichinose
Takashi Seto
Hiroshi Sakai
Akihiko Gemma
Fumio Imamura
Masato Shingyoji
Hideo Saka
Akira Inoue
Koji Takeda
Isamu Okamoto
Katsuyuki Kiura
Satoshi Morita
Tomohide Tamura
机构：
[1] Sendai Kousei Hospital,Department of Pulmonary Medicine
[2] Kindai University,Department of Medical Oncology, Faculty of Medicine
[3] Wakayama Medical University,Third Department of Internal Medicine
[4] National Cancer Center Hospital,Department of Thoracic Oncology
[5] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Thoracic Medical Oncology
[6] Shizuoka Cancer Center,Division of Thoracic Oncology
[7] National Cancer Center Hospital East,Department of Thoracic Oncology
[8] Miyagi Cancer Center,Department of Respiratory Medicine
[9] Clinical Research Institute,Department of Cancer Information Research, National Kyushu Cancer Center
[10] National Kyushu Cancer Center,Department of Thoracic Oncology
[11] Saitama Cancer Center,Department of Thoracic Oncology
[12] Nippon Medical School,Department of Pulmonary Medicine and Oncology, Graduate School of Medicine
[13] Osaka International Cancer Institute,Department of Thoracic Oncology
[14] Chiba Cancer Center,Division of Respirology
[15] National Hospital Organization Nagoya Medical Center,Department of Respiratory Medicine and Medical Oncology
[16] Tohoku University School of Medicine,Department of Palliative Medicine
[17] Osaka City General Hospital,Department of Medical Oncology
[18] Kyushu University,Research Institute for Diseases of the Chest, Graduate School of Medical Sciences
[19] Okayama University Graduate School of Medicine,Department of Hematology, Oncology, and Respiratory Medicine
[20] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
[21] St Luke’s International Hospital,Thoracic Center
来源：
International Journal of Clinical Oncology | 2019年 / 24卷
关键词：
Tegafur–gimeracil–oteracil; Second line; Third line; Chemotherapy; Japan; Phase III;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：485 / 493
页数：8
相关论文
共 50 条
  • [1] Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC
    Sugawara, Shunichi
    Nakagawa, Kazuhiko
    Yamamoto, Nobuyuki
    Nokihara, Hiroshi
    Ohe, Yuichiro
    Nishio, Makoto
    Takahashi, Toshiaki
    Goto, Koichi
    Maemondo, Makoto
    Ichinose, Yukito
    Seto, Takashi
    Sakai, Hiroshi
    Gemma, Akihiko
    Imamura, Fumio
    Shingyoji, Masato
    Saka, Hideo
    Inoue, Akira
    Takeda, Koji
    Okamoto, Isamu
    Kiura, Katsuyuki
    Morita, Satoshi
    Tamura, Tomohide
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (05) : 485 - 493
  • [2] Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer
    Atagi, Shinji
    Kawahara, Masaaki
    Kusunoki, Yoko
    Takada, Minoru
    Kawaguchi, Tomoya
    Okishio, Kyoiti
    Kubo, Akihito
    Uehira, Kazutaka
    Yumine, Katsuyuki
    Tomizawa, Yoshio
    Saito, Ryusei
    Fukai, Shimao
    Komatsu, Hikotaro
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1012 - 1017
  • [3] East Asian Subgroup Analysis of a Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy (REVEL)
    Park, Keunchil
    Kim, Joo-Hang
    Cho, Eun Kyung
    Kang, Jin-Hyoung
    Shih, Jin-Yuan
    Zimmermann, Annamaria Hayden
    Lee, Pablo
    Alexandris, Ekaterine
    Puri, Tarun
    Orlando, Mauro
    CANCER RESEARCH AND TREATMENT, 2016, 48 (04): : 1177 - 1186
  • [4] A randomized, double-blind, phase II study of ramucirumab plus docetaxel vs placebo plus docetaxel in Japanese patients with stage IV non-small cell lung cancer after disease progression on platinum-based therapy
    Yoh, Kiyotaka
    Hosomi, Yukio
    Kasahara, Kazuo
    Yamada, Kazuhiko
    Takahashi, Toshiaki
    Yamamoto, Nobuyuki
    Nishio, Makoto
    Ohe, Yuichiro
    Koue, Toshiko
    Nakamura, Takashi
    Enatsu, Sotaro
    Lee, Pablo
    Ferry, David
    Tamura, Tomohide
    Nakagawa, Kazuhiko
    LUNG CANCER, 2016, 99 : 186 - 193
  • [5] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Oizumi, Satoshi
    Yamazaki, Koichi
    Yokouchi, Hiroshi
    Konishi, Jun
    Hommura, Fumihiro
    Kojima, Tetsuya
    Isobe, Hiroshi
    Nishimura, Masaharu
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 125 - 129
  • [6] Phase I study of amrubicin and vinorelbine in non-small cell lung cancer previously treated with platinum-based chemotherapy
    Satoshi Oizumi
    Koichi Yamazaki
    Hiroshi Yokouchi
    Jun Konishi
    Fumihiro Hommura
    Tetsuya Kojima
    Hiroshi Isobe
    Masaharu Nishimura
    International Journal of Clinical Oncology, 2009, 14 : 125 - 129
  • [7] Efficacy of subsequent docetaxel plus /- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancer
    Tamura, Nobumasa
    Horinouchi, Hidehito
    Sekine, Katsutoshi
    Matsumoto, Yuji
    Murakami, Shuji
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Yamamoto, Noboru
    Ohe, Yuichiro
    THORACIC CANCER, 2019, 10 (05) : 1141 - 1148
  • [8] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Naoki, Katsuhiko
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Satomi, Ryosuke
    Nakayama, Sohei
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Morosawa, Maiko
    Asano, Koichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 717 - 722
  • [9] Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer
    Shiroyama, Takayuki
    Komuta, Kiyoshi
    Imamura, Fumio
    Hirashima, Tomonori
    Kijima, Takashi
    Tachibana, Isao
    Kawase, Ichiro
    LUNG CANCER, 2011, 74 (01) : 85 - 88
  • [10] RANDOMIZED PHASE III TRIAL OF S-1 PLUS CISPLATIN VERSUS DOCETAXEL PLUS CISPLATIN FOR ADVANCED NON-SMALL-CELL LUNG CANCER (TCOG0701): SUBGROUP ANALYSIS
    Ishimoto, Osamu
    Gemma, Akihiko
    Sakai, Hiroshi
    Katakami, Nobuyuki
    Kubota, Kaoru
    Nishio, Makoto
    Inoue, Akira
    Okamoto, Hiroaki
    Isobe, Hiroshi
    Kunitoh, Hideo
    Takiguchi, Yuichi
    Kobayashi, Kunihiko
    Nakamura, Yoichi
    Ohmatsu, Hironobu
    Minato, Kouichi
    Fukuda, Masaaki
    Yokoyama, Akira
    Takeuchi, Masahiro
    Michimae, Hirofumi
    Kudoh, Shoji
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S193 - S193
12345